Pages with the most revisions

Showing below up to 250 results in range #1 to #250.

1. Alternative Energy/Paper‏‎ (558 revisions)
2. Alternative Energy/Give an overall picture of the AE field‏‎ (226 revisions)
3. Diagnostic Kits/Paper‏‎ (200 revisions)
4. Alternative Energy‏‎ (179 revisions)
5. Alternative Energy/IP Profile of Biggest for-profit companies in AE‏‎ (172 revisions)
6. Diagnostic Kits‏‎ (145 revisions)
7. Educational Materials‏‎ (134 revisions)
8. Overall Picture of the EM field‏‎ (121 revisions)
9. Report April 2009‏‎ (114 revisions)
10. Diagnostic Kits/Glossary‏‎ (112 revisions)
11. Diagnostic Kits/Case Law Review‏‎ (109 revisions)
12. Overall Picture of the EM-K12 field‏‎ (108 revisions)
13. Alternative Energy/Country AE Profiles‏‎ (104 revisions)
14. Alternative Energy/IP Profile of non-profit companies in AE‏‎ (103 revisions)
15. Diagnostic Kits/IP in Kits‏‎ (102 revisions)
16. Main Page‏‎ (98 revisions)
17. Biotechnology - Genomic and Proteomics/Overview of Economics of Intellectual Property in BGP‏‎ (84 revisions)
18. Biotechnology - Genomic and Proteomics/Data, narratives and tools produced by the BGP field‏‎ (81 revisions)
19. Report September 2009‏‎ (74 revisions)
20. Biotechnology - Genomic and Proteomics/Give an overall picture of the BGP field‏‎ (69 revisions)
21. Educational Materials/Paper‏‎ (68 revisions)
22. Biotechnology - Genomic and Proteomics‏‎ (67 revisions)
23. Telecommunications‏‎ (65 revisions)
24. Diagnostic Kits/Page for Joint Creation of Blog Post‏‎ (58 revisions)
25. Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP/BGP Company Profiles - Data‏‎ (54 revisions)
26. Diagnostic Kits/Give an overall picture of the Kits' sector‏‎ (52 revisions)
27. Diagnostic Kits/USA Regulation Review‏‎ (51 revisions)
28. Alternative Business Models in EM‏‎ (51 revisions)
29. Main Page/ICP Team‏‎ (50 revisions)
30. Diagnostic Kits/Commons based cases in Kits‏‎ (49 revisions)
31. Alternative Energy/Overview of Economics of Intellectual Property in AE‏‎ (49 revisions)
32. Alternative Energy/Bibliography by Research Question‏‎ (48 revisions)
33. Commons-based Cases in EM‏‎ (43 revisions)
34. Diagnostic Kits/Overview of Economics of Intellectual Property in Kits‏‎ (43 revisions)
35. Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP‏‎ (40 revisions)
36. IP Profile of Biggest for-profit companies in EM‏‎ (39 revisions)
37. Introduction to Telecommunications Industries‏‎ (38 revisions)
38. EFRC Energy Frontier Research Centers (EFRCs)‏‎ (36 revisions)
39. Bibliography for Item 2 in BGP‏‎ (36 revisions)
40. Main Page/Industrial Cooperation Project‏‎ (35 revisions)
41. Diagnostic Kits/Data, narratives and tools produced by the Kits' sector‏‎ (35 revisions)
42. Alternative Energy/Innovations in Wind, Solar and Tidal‏‎ (35 revisions)
43. Bacterias for Energy‏‎ (34 revisions)
44. Biotechnology - Genomic and Proteomics/Commons based cases in BGP‏‎ (33 revisions)
45. AC Weekly tasks and results‏‎ (33 revisions)
46. United States Country Report (Diagnostic Kits)‏‎ (33 revisions)
47. Contacts for EM‏‎ (33 revisions)
48. Links on EM‏‎ (32 revisions)
49. Report May 2009‏‎ (31 revisions)
50. Main Page/ICP Reports and Working Papers‏‎ (31 revisions)
51. IP Profile of Universities working in EM‏‎ (31 revisions)
52. Biotechnology - Genomic and Proteomics/Overview of Economics of Intellectual Property in BGP/Bibliography for Item 1 in BGP‏‎ (30 revisions)
53. Diagnostic Kits/IP Profile of Universities working in Kits‏‎ (29 revisions)
54. Alternative Energy/IP Profile of Universities working in AE‏‎ (28 revisions)
55. Alternative Energy/AE Essay on EFRC Survey‏‎ (28 revisions)
56. Paper Resources Used‏‎ (28 revisions)
57. Report October 2009‏‎ (28 revisions)
58. ICP Sectors‏‎ (27 revisions)
59. IP Profile of Associations in EM‏‎ (26 revisions)
60. Diagnostic Kits/Bibliography by Research Question‏‎ (26 revisions)
61. Educational Materials/Bibliography by Resource Type‏‎ (25 revisions)
62. California‏‎ (24 revisions)
63. Educational Materials/Bibliography by Research Question‏‎ (22 revisions)
64. Houghton Mifflin Harcourt‏‎ (22 revisions)
65. Alternative Energy/Commons based cases in AE‏‎ (22 revisions)
66. Overview of Economics of Intellectual Property in EM‏‎ (22 revisions)
67. Diagnostic Kits/The Argument Framework‏‎ (20 revisions)
68. Alternative Energy/EFRC Technology Focus‏‎ (19 revisions)
69. Data, narratives and tools produced by the EM field‏‎ (18 revisions)
70. IP Profile of Biggest for-profit companies in EM-K12‏‎ (18 revisions)
71. Diagnostic Kits/Bibliography by Resource Type‏‎ (18 revisions)
72. Commons-based Cases in EM-K12‏‎ (18 revisions)
73. ICP Parking Lot/Algae for Energy‏‎ (18 revisions)
74. Textbooks‏‎ (17 revisions)
75. Biotechnology - Genomic and Proteomics/Sage - A Merck Project‏‎ (17 revisions)
76. Diagnostic Kits/Competitive advantages in Kits‏‎ (17 revisions)
77. ICP Parking Lot/Vaccines‏‎ (16 revisions)
78. Bibliography for Item 11 in AE‏‎ (15 revisions)
79. Pearson‏‎ (15 revisions)
80. Cengage Learning‏‎ (15 revisions)
81. Bibliography for Item 3 in BGP‏‎ (15 revisions)
82. Texas‏‎ (15 revisions)
83. IP Profile of non-profit companies in EM‏‎ (14 revisions)
84. Bibliography for Item 6 in BGP‏‎ (14 revisions)
85. Diagnostic Kits/SACGHS Gene Patents and Licensing Practices Final Report‏‎ (14 revisions)
86. McGraw-Hill‏‎ (14 revisions)
87. Biotechnology - Genomic and Proteomics/IP Profile of Universities working in BGP‏‎ (14 revisions)
88. Biotechnology - Genomic and Proteomics/Open Business models in BGP‏‎ (14 revisions)
89. ICP wiki site map‏‎ (14 revisions)
90. Diagnostic Kits/The licensing of DNA patents by US academic institutions‏‎ (14 revisions)
91. Diagnostic Kits/SACGHS Gene Patents and Licensing Practices‏‎ (13 revisions)
92. Biotechnology - Genomic and Proteomics/IP in BGP‏‎ (12 revisions)
93. Competitive advantages in EM-K12‏‎ (12 revisions)
94. Wiley‏‎ (12 revisions)
95. IP in EM‏‎ (12 revisions)
96. Alternative Energy/Competitive advantages in AE‏‎ (12 revisions)
97. Bibliography for Item 1 in BGP/Murray et all - here‏‎ (12 revisions)
98. IP Profile of Associations in EM-K12‏‎ (12 revisions)
99. ICP Parking Lot/Sustainability‏‎ (11 revisions)
100. EG Weekly Tasks and Results‏‎ (11 revisions)
101. Blogs to watch on EM‏‎ (11 revisions)
102. Biotechnology - Genomic and Proteomics/Competitive advantages in BGP‏‎ (11 revisions)
103. Reed Elsevier‏‎ (10 revisions)
104. IP Profile of non-profit companies in EM-K12‏‎ (10 revisions)
105. Diagnostic Kits/Priorities for Personalized Medicine‏‎ (10 revisions)
106. Hal Plotkin Interview Notes - August 10, 2009‏‎ (10 revisions)
107. Alternative Energy/Bibliography for Item 6 in AE‏‎ (10 revisions)
108. Bibliography for Item 12 in BGP‏‎ (9 revisions)
109. Value Chain in Telecommunications‏‎ (9 revisions)
110. Diagnostic Kits/Patents and the Progress of Personalized Medicine‏‎ (9 revisions)
111. Main Page/ICP Complete Bibliography‏‎ (8 revisions)
112. NIH Web Based Survey of DNA-Based Patents‏‎ (8 revisions)
113. Alternative Energy/Impacts of Intellectual Property in AE‏‎ (8 revisions)
114. Competitive advantages in EM‏‎ (8 revisions)
115. Diagnostic Kits/The dangers of diagnostic monopolies‏‎ (8 revisions)
116. Biotechnology - Genomic and Proteomics/IP Profile of Associations in BGP‏‎ (8 revisions)
117. Alternative Energy/IP Profile of Associations in AE‏‎ (8 revisions)
118. General Bibliography for EM‏‎ (8 revisions)
119. Diagnostic Kits/IP Profile of Biggest for-profit companies in Kits‏‎ (8 revisions)
120. Diagnostic Kits/NIH Principles and Guidelines for Sharing of Biomedical Resources‏‎ (7 revisions)
121. Economics of Intellectual Property in BGP Bibliography‏‎ (7 revisions)
122. Bibliography for Item 5 in BGP‏‎ (7 revisions)
123. Florida‏‎ (7 revisions)
124. Diagnostic Kits/Biotechnology and Intellectual Property Reinventing the Commons‏‎ (7 revisions)
125. Diagnostic Kits/The market economy and the scientific commons‏‎ (7 revisions)
126. Harcourt Education‏‎ (6 revisions)
127. Diagnostic Kits/IP Profile of Associations in Kits‏‎ (6 revisions)
128. Overview of Economics of Intellectual Property in EM-K12‏‎ (6 revisions)
129. AE Essay on EFRC Survey/EFRC Resources and Bibliography‏‎ (6 revisions)
130. History of EM Field‏‎ (6 revisions)
131. IP Profile of Universities working in EM-K12‏‎ (6 revisions)
132. Verlagsgruppe Georg von Holtzbrinck‏‎ (6 revisions)
133. Vaccines/Sara Crager on Vaccines‏‎ (6 revisions)
134. Defining the Commons‏‎ (6 revisions)
135. Bibliography for Item 4 in BGP‏‎ (6 revisions)
136. Bibliography for Item 8 in BGP‏‎ (6 revisions)
137. Diagnostic Kits/IP Profile of non-profit companies in Kits‏‎ (6 revisions)
138. Diagnostic Kits/Changing Winds For Gene Patenting In the US‏‎ (6 revisions)
139. Biotechnology - Genomic and Proteomics/IP Profile of non-profit companies in BGP‏‎ (6 revisions)
140. The K-12 Level‏‎ (6 revisions)
141. Economics of Intellectual Property in Telecommunications‏‎ (6 revisions)
142. Bibliography for Item 10 in BGP‏‎ (5 revisions)
143. IP in EM-K12‏‎ (5 revisions)
144. Bibliography for Item 9 in BGP‏‎ (5 revisions)
145. Diagnostic Kits/Genes and ingenuity: gene patenting and human health report‏‎ (5 revisions)
146. Alternative Business Models in EM-K12‏‎ (5 revisions)
147. Europe Country Report‏‎ (5 revisions)
148. Diagnostic Kits/Country Reports Review‏‎ (5 revisions)
149. Diagnostic Kits/Peer-Production Business models in Kits‏‎ (5 revisions)
150. Diagnostic Kits/Patent pools and diagnostic testing‏‎ (5 revisions)
151. Peter Levy Interview Notes - September 18, 2009‏‎ (5 revisions)
152. Diagnostic Kits/DNA Patenting and Licensing‏‎ (5 revisions)
153. Diagnostic Kits/Nonenforcement, Noneproblem Rethinking the Anticommons in Biomedical Research‏‎ (5 revisions)
154. Alternative Energy/Bibliography by Resource Type‏‎ (5 revisions)
155. Katherine Dykes‏‎ (5 revisions)
156. E-Book Readers‏‎ (5 revisions)
157. Biotechnology - Genomic and Proteomics/Others‏‎ (5 revisions)
158. Questionnaire for Case Studies‏‎ (5 revisions)
159. Diagnostic Kits/The Search for Alternatives to Patents in the 21st Century‏‎ (5 revisions)
160. Joel Thierstein Interview Notes - August 19, 2009‏‎ (4 revisions)
161. Walt Musial‏‎ (4 revisions)
162. Ahrash Bissell Interview Notes - July 20, 2009‏‎ (4 revisions)
163. Alternative Energy/Innovation and Technology Transfer to Address Climate Change‏‎ (4 revisions)
164. ICP Parking Lot‏‎ (4 revisions)
165. Neeru Khosla Interview Notes - September 4, 2009‏‎ (4 revisions)
166. Ahrash Bissell Interview Notes - May 12, 2009‏‎ (4 revisions)
167. BGP Company Profiles - Data/BGP Table of Biggest For-Profit Companies‏‎ (4 revisions)
168. Research Methodology Index for Telecommunications‏‎ (4 revisions)
169. Diagnostic Kits/Effects of patents and licenses on the provision of clinical genetic testing services‏‎ (4 revisions)
170. Alternative Energy/Original emails with Dr. Robin Hayes‏‎ (4 revisions)
171. Educational Materials/Interviews‏‎ (4 revisions)
172. The Higher Education Level‏‎ (4 revisions)
173. SACGHS Appendix 1- Compendium of Case Studies on the Impact of Gene Patents and Licensing Practices on Access to Genetic Testing‏‎ (4 revisions)
174. Diagnostic Kits/Interviews‏‎ (4 revisions)
175. Diagnostic Kits/Legal uncertainty in the area of genetic diagnostic testing‏‎ (4 revisions)
176. Economics of IP Bibliography‏‎ (4 revisions)
177. Data, narratives and tools produced by the EM-K12 field‏‎ (4 revisions)
178. Legislation on Policy Theme 1 for EM‏‎ (4 revisions)
179. Cathy Swift Interview Notes - September 21, 2009‏‎ (4 revisions)
180. Economics of Intellectual Property‏‎ (4 revisions)
181. Victor Cardona‏‎ (4 revisions)
182. Lessig‏‎ (4 revisions)
183. Laura Diaz Anadon‏‎ (4 revisions)
184. Diagnostic Kits/A clearing house for diagnostic testing: the solution to ensure access to and use of patented genetic inventions‏‎ (3 revisions)
185. Diagnostic Kits/A pilot survey on the licensing of DNA inventions‏‎ (3 revisions)
186. Diagnostic Kits/Diagnostics and biomarker development- priming the pipeline‏‎ (3 revisions)
187. Kathi Fletcher Interview Notes - August 26, 2009‏‎ (3 revisions)
188. Diagnostic Kits/Open Business models in Kits‏‎ (3 revisions)
189. Diagnostic Kits/Diagnostic Test Service Commercialization in Multiplex and Esoteric Testing‏‎ (3 revisions)
190. Alternative Energy/EFRCs Survey Questions‏‎ (3 revisions)
191. Diagnostic Kits/Models for facilitating access to patents on genetic inventions‏‎ (3 revisions)
192. /Diagnostic Kits/Nature on open data‏‎ (3 revisions)
193. Diagnostic Kits/Diagnostic Test Service Commercialization- A Roadmap to Diagnostics in the 21st Century‏‎ (3 revisions)
194. Diagnostic Kits/Old notes IP‏‎ (3 revisions)
195. EurObserv-ER reports‏‎ (3 revisions)
196. Michael Dworkin‏‎ (3 revisions)
197. Possible journal or working paper submission sites‏‎ (3 revisions)
198. Diagnostic Kits/Analysing DNA patents in relation with diagnostic genetic testing‏‎ (3 revisions)
199. Diagnostic Kits/Patents limit medical potential of sequencing‏‎ (3 revisions)
200. Bobbi Kurshan Interview Notes - August 17, 2009‏‎ (3 revisions)
201. Diagnostic Kits/SACGHS U.S. System of Oversight of Genetic Testing‏‎ (3 revisions)
202. Diagnostic Kits/Diagnostic testing fails the test‏‎ (3 revisions)
203. Jonathan Emmons Interview Notes - March 25, 2009‏‎ (3 revisions)
204. Anne Schreiber Interview Notes - August 31, 2009‏‎ (3 revisions)
205. Diagnostic Kits/Disease Gene Patents‏‎ (3 revisions)
206. New Energy Movement Director‏‎ (3 revisions)
207. Telecommunications/Background Research and Resources‏‎ (3 revisions)
208. Data, narratives and tools produced by the Kits' sector/GeneDxChart‏‎ (3 revisions)
209. Diagnostic Kits/Morrison and Foerster Represents ACON Laboratories in $175 Million Acquisition by Inverness Medical Innovations‏‎ (3 revisions)
210. Anne Schreiber Interview Notes - August 27, 2009‏‎ (3 revisions)
211. Australia Country Report‏‎ (3 revisions)
212. Benkler‏‎ (3 revisions)
213. Biotechnology - Genomic and Proteomics/Peer-Production Models in BGP‏‎ (3 revisions)
214. Boyle‏‎ (3 revisions)
215. Diagnostic Kits/Nature on Open Data‏‎ (3 revisions)
216. Diagnostic Kits/The Manchester Manifesto‏‎ (3 revisions)
217. Diagnostic Kits/Intellectual Property Landscape of the Human Genome‏‎ (3 revisions)
218. Lessons from ANT‏‎ (3 revisions)
219. Diagnostic Kits/Testing new ground‏‎ (3 revisions)
220. Diagnostic Kits/The Value of Diagnostics: Innovation, Adoption and Diffusion Into Health Care‏‎ (3 revisions)
221. Government in BGP‏‎ (3 revisions)
222. Industrial Cooperation Project/ICP Questions‏‎ (3 revisions)
223. Adam Holland‏‎ (3 revisions)
224. Legislation on Policy Theme 6 for EM‏‎ (2 revisions)
225. William Bonvillian‏‎ (2 revisions)
226. John Liebovitz Feedback Notes‏‎ (2 revisions)
227. Peter Mandelstam‏‎ (2 revisions)
228. Diagnostic Kits/Direct-to-consumer genetic testing- two sides of the coin‏‎ (2 revisions)
229. Bill Hughes Interview Notes - October 7, 2009‏‎ (2 revisions)
230. Diagnostic Kits/Clinically Available Pharmacogenomics Tests‏‎ (2 revisions)
231. Legislation on Policy Theme 9 for EM‏‎ (2 revisions)
232. Diagnostic Kits/Diagnosis or drug- Will pharmaceutical companies or diagnostics manufacturers earn more from personalized medicine‏‎ (2 revisions)
233. Report June 2009‏‎ (2 revisions)
234. Diagnostic Kits/DNA-based patents: an empirical analysis‏‎ (2 revisions)
235. Legislation on Policy Theme 5 for EM‏‎ (2 revisions)
236. WORKING‏‎ (2 revisions)
237. Charles Weiss‏‎ (2 revisions)
238. Diagnostic Kits/Peer-Production Business models in Kits/CHDWiki‏‎ (2 revisions)
239. IP Profile of Biggest for-profit companies in BGP/Publishing Companies with focus on BGP‏‎ (2 revisions)
240. IP Profile of Biggest for-profit companies in BGP/BGP Company Profiles‏‎ (2 revisions)
241. Meeting with Yochai‏‎ (2 revisions)
242. Diagnostic Kits/Glossary/Generics‏‎ (2 revisions)
243. Energy conversion efficiencies‏‎ (2 revisions)
244. ETextbooks‏‎ (2 revisions)
245. Legislation on Policy Theme 2 for EM‏‎ (2 revisions)
246. Test‏‎ (2 revisions)
247. Diagnostic Kits/Patents versus patenting: implications of intellectual property protection for biological research‏‎ (2 revisions)
248. KEI study‏‎ (2 revisions)
249. Bibliography for Item 11 in BGP‏‎ (2 revisions)
250. Questions for Genentech‏‎ (2 revisions)